Schedule 13G ownership disclosure

Denali Therapeutics Inc

Security class unavailable · CUSIP: 24823R105

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
20,415,535
Percent of class
21.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001011438-20-000068
Form type
SC 13G/A
Filer
BRATTON DOUGLAS K
CIK
CIK 1281933
Filed
Feb 11, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub